Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
CART Therapy for Multiple Myeloma
Recruiting1 awardPhase 1
Philadelphia, Pennsylvania
This trial is testing a new cancer treatment regimen that is based on an established safe treatment. The new regimen is being tested for safety and how well it works in patients with multiple myeloma who are responding to first- or second-line therapy.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service